Real-world Effectiveness and Usage of Voclosporin: Data from the ENLIGHT-LN Registry Presenting Author: Leanna Wise, M.D., ...
There is lower risk for mortality in patients with cardio-renal-metabolic multimorbidity who maintain hematologic parameters within optimal ranges.
The kidneys sometimes produce hard mineral deposits known as kidney stones, which trigger severe pain, and can result in additional health complications. The management of kidney stone risk heavily ...
Creatinine is a byproduct of muscle metabolism and under normal circumstances, the kidney's filter creatinine from the blood and pass it out of the body in the form of urine. If the kidney function ...
As a dietitian, I spend a lot of time talking about how food impacts our bodies, from our hearts to our guts. But one pair of organs often gets overlooked until there’s a problem: our kidneys. These ...
Scientists have uncovered how lymphatic vessels—the kidney's "plumbing system"—undergo dramatic changes during chronic transplant rejection, becoming structurally disorganized and spreading to unusual ...
A novel pill that blocks the hormone aldosterone shows promise for lowering blood pressure and potentially delaying the progression of kidney disease in people with both conditions. The preliminary ...
In a landmark move, the US Food and Drug Administration (FDA) has given biotech company eGenesis the go-ahead to conduct a broader human trial in pig-to-human kidney transplants, marking a significant ...
Nine out of 10 people with chronic kidney disease only find out when it progresses to later stages. Here’s what we know about its risk factors—and why there's new reason to hope for more effective ...
QUEST TO IDENTIFY RHEA RASMUSSEN. WE HAVE MORE BREAKING NEWS NOW THAT WE ARE FOLLOWING THIS. NOON. A SECOND NEW HAMPSHIRE MAN HAS NOW RECEIVED A SUCCESSFUL KIDNEY TRANSPLANT. THE GRANITE STATERS ARE ...
In this Ask The Professor Q&A, David St-Jules, a registered dietitian and assistant professor in the Department of Nutrition, and Dr. John Westhoff, associate professor in the School of Medicine and ...
A Cambridge biotech company and Boston doctors have received federal approval to start the nation’s first clinical trial of genetically engineered pig kidney transplants in people with end-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results